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Health Sciences, The Aga Khan University, Karachi-74800. ) 
ABSTRACT 
In order to determine the prevalence of glucose intolerance in pregnancy, 1267 consecutive women
attending the antenatal clinic of the Aga khan University Medical Centre were subjected to a 75g
glucose challenge followed 2hr later by plasma glucose determination irrespective of gestation on the
first antenatal visit. The test was repeated at 28-32 weeks of gestation if the patients had an abnormal
initial screen at < 28 weeks gestation and a normal glucose tolerance test on diagnostic follow-up and
for those who had a risk factor for gestational diabetes and a normal initial screen at < 28 weeks
gestation. The glucose challenge test was abnormal (2hr plasma glucose> 1 40mg%) in 8.6% of the
screened population. Follow-up oral glucose tolerance test on these patients revealed a prevalence of
3.2% of gestationat diabetes and 1.9% of impaired glucose tolerance test based on the modified
O’Sullivan criteria. Improvement in cost effectiveness of screening programmes was adjudged possible
by avoiding glucose tolerance tests in patients with 2hr plasma glucose value of > 170mg% after a 75g
oral glucose challenge for screening (JPMA 41:31, 1991).
INTRODUCTION 
Gestational diabetes has been identified as a distinct entity deserving increased recognition, treatment
and research. 1,2Its prevalence varies from 0.15% in New Castle(UK) to 1.8% in Nairobi and 1.9% in
Riyadh to 2.5 -7.5% in Boston3,4. The differences observed maybe due to variations in the weight of
the glucose load used for the glucose tolerance test and in the criteria used for assessing abnormality. In
Pakistan where the prevalence of gestational diabetes in largely undetermined, there is good reason to
believe that it maybe high. As diabetes has a genetic basis at least asstrongas the environmental one,
frequent intermarriages as well as poor dietary habits may contribute to this presumed high prevalence.
While controversy prevails over screening strategies and diagnostic criteria, 3,5,6 we report our
experience with an ongoing programme of screening for diabetes in all women attending the antenatal
clinics during one year (1988-89).
SUBJECTS AND METHODS 
The study population included the first 1267 pregnant women registering at the Aga Khan University
Medical Centre Karachi, from July 1988 to June 1989. Women known not to be diabetic before the
onset of pregnancy were screened for abnormal carbohydrate metabolism. On the first visit to the
antenatal clinic a 75g glucose challenge test (GCT) was scheduled irrespective of gestational age. This
was part of the patients routine prenatal care. Fasting was not required although most women came
fasting on the day of the screen. A dose of 75g glucose was dissolved in about 300ml of fluid and
administered orally Over a 5 minute period. A single venous blood sample was obtained 2hr later for
plasma glucose determination. The results were available for review at the next antenatal visit. Any
subject with a plasma value of > 140g% underwent a formal glucose tolerance test (GTT). The subjects
consumed an unrestricted carbohydrate diet for at least 3 days prior to the GTT and came fasting for
10-12hrs on the morning of the test. After an initial venous blood sample was drawn, a 75g oral glucose
load was given as for the GCT. Further venous blood samples were obtained at 1,2 and 3hrs after the
glucose load for determination of plasma glucose. The plasma glucose was determined in all the blood
samples by the hexokinase method using as autoanalyser. The diagnosis of abnormality of glucose
tolerance was based on the Modified O’Sullivan criteria.7 Plasma glucose values of > 105mg%, >
186mg%, > 140mg% and 122mg% for the fasting, 1hr, 2hr and 3hr samples respectively were
considered abnormal. To make a diagnosis of gestational diabetes mellitus (GDM) at least 2 abnormal
values were required, whereas a single abnormal value was sufficient to make the diagnosis of impaired
glucose tolerance test (IGTT). GCT was repeated at 28-32 weeks on women who were screened before
28 weeks of gestation, the GCT if the initial GCT was abnormal followed by a normal GTT and for
those who had an initial normal GCT but presented with features of potential diabetes i.e. close family
history of diabetes, previously delivered macrosomic baby, past history of unexplained
stillbirth/neonatal death. A repeat GTT was carried out if the plasma glucose level was > 14Omg% on
the repeat GCT The two sample t test was used for comparison of differences between means.
RESULTS 
Of 1267 consecutive women screened 109(8.6%) had an abnormal GCT (Table-1).
Of these 109 subjects 60 were detected at the initial screen before 28 weeks and 26 after 28 weeks
gestation, while 23 women had an abnormal GCT when the screen was repeated according to the
criteria outlined in methods. The mean age of all women screened was 27.8 (SD6.1) yrs, and of women
with abnormal GCT 28.8 (SD 4.3) yrs. There were 31 (28.4%) and 601 (51.9%) primiparous women
among those with an abnormal and normal GCT respectively. The difference for ages was statistically
insignificant (P >0.05) and that for parity was significant (P <0.05). Of the 109 women with an
abnormal GCT, 102 underwent a GIT as 7 subjects were excluded (3 did not return, 2 had late abortions
and 2 could not complete the test due to vomiting). GTF’s were normal in 38 and abnormal in 64
women (Table II).
Based on the abnormal GT1 GDM was diagnosed in 41 and IGTT in 23 giving a prevalence of 3.2%
and L9% respectively. The mean plasma glucose value of the GCT of 38 subjects with a normal GTT
was significantly different (P <0.001) from the mean plasma glucose value in GCT of 41 women found
to have GDM (Table-III).
DISCUSSION 
The frequency of recognition of gestational diabetes is directly related to the intensity of screening
programmes. Poor pick up rates from screening only selected patients based on risk evaluation10,11 has
generated recommendations of screening all pregnant women1,2. In our hospital such a screening
programme was instituted in July1988 and acceptance of the pregnant women has been good. Except
for 2 patients who had vomiting, no other patients complained about the taste or volume of glucose
solution, nor did they mind the 2hr waiting time for the blood sample to be drawn. For administering
the GCT, a 75g glucose challenge was chosen in preference to a 50g challenge (recommended by
O’Sullivan) as the better efficiency of the former has been shown by Markatz8 and it has also been
recommended by WHO1. In view of increasing awareness that minor degrees of carbohydrate
intolerance considered to be within normal range as judged by currently available criteria, can
adversely affect pregnancy outcome, 16 stricter criteria for diagnosing abnormal glucose tolerance in
pregnancy should be used. We selected the O’Sullivan’s criteria9 rather than the WHO criteria1 because
the latter are the same for both the pregnant and the non-pregnant state and hence do not take into
account the physiological alterations of carbohydrate metabolism in pregnancy. The prevalence of
abnormal GCT in our study was 8.6%. This compares to the 6.1% and 19.3% reported by Beard12 and
Al- Shawaf. 4 The majority of these patients were picked up on the first antenatal visit prior to 28
weeks gestation (Table 1) which supports the suggestion to screen in early pregnancy as opposed to
postponing the screening till the 27th week of gestation as suggested by Peterson. 13 Early screening
and pickup have the advantage of providing an opportunity to institute therapy in early pregnancy. In
our series, the prevalence rates of GDM and IGTT are 3.2% and 1.9% respectively which are higher
than those reported from the West. 3,4,12,14, is of interest to note that the prevalence of GDM in our
study (3.2%) is higher than the 1.9% prevalence reported from Riyadh4 where the diagnosis was based
on O’Sullivan’s criteria like in our study as well as on WHO criteria. We found that IGTT (1.9%) was
diagnosed in a significantly lower proportion of our women than 8.4% reported by Al-Shawat1 who
used WHO criteria. This could be that due to the use of WHO criteria which tends to diagnose more
patients with IGTT than with GDM. This is due to the relatively high critical fasting value of 140mg%
which does not take into account the fasting hypoglycemia of normal pregnancy. The risk of having
GDM in patients with an abnormal screening GCT (positive predictive value’ of GCT) in our study was
41.8% which is much higher than the 9.8% obtained from screening at Riyadh. 4 The reason for this
difference is not clear, but it could be due to geographical, ethnic and racial variations in the pattern of
carbohydrate intolerance. 3 The mean glucose value in the GC’F of women with normal GTT and in
those with GDM are significantly different (Table Ill). Based on this observation we would propose that
women who are found to have a 2hr plasma glucose level on GCT of <170mg% (which is the mean +
2SD. of the plasma glucose level of the subjects with normal GTF) could be used as a cut-off point
above which a diagnosis of abnormal glucose tolerance could be made without the need for a GIT In
our series there were 18 patients with GDM/IGTT who had a GCT of > 170mg%. However there was
one patient who had a GC’F of > 170mg% but was found to have a normal GTT Such an approach will
increase the cost-effectiveness of screening programmes which is very important for developing
countries where resources are limited.
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